1. Systematic HIPAA Privacy Failures - Average Cost: $347,000
The most expensive compliance violation category for pharmacies in 2025 was not a single incident but a pattern: systematic failures in HIPAA privacy practices identified through breach investigations or complaint-driven audits.
OCR settled five pharmacy-specific cases in 2025 for amounts ranging from $85,000 to $1.25 million. The common thread was not a single data breach event but rather the investigation uncovering multiple, long-standing compliance gaps - missing risk analyses, absent Business Associate Agreements, no evidence of workforce training, and inadequate access controls.
The key insight is that OCR rarely punishes the initial breach as harshly as it punishes the underlying compliance program failures the investigation reveals. A pharmacy with a documented compliance program, current risk analysis, and trained staff that experiences a breach faces a very different outcome than one that cannot demonstrate basic privacy safeguards.
2. DEA Registration Violations and Revocations - Average Cost: $189,000
DEA enforcement against pharmacies escalated significantly in 2025. The average cost combines direct fines (median $67,500) with the operational impact of registration suspensions, legal fees, and business interruption.
The most common triggers were failure to maintain accurate controlled substance inventories, dispensing without corresponding responsibility documentation, and failure to report losses or significant shortages. In several high-profile cases, pharmacies lost their DEA registration entirely - effectively a death sentence for the business.
What makes DEA violations particularly costly is the speed of enforcement. Immediate suspension orders bypass the normal administrative hearing process. A pharmacy can go from operating normally to shut down within 24 hours, with no opportunity to cure the deficiency before the action takes effect.
3. Compound Claim PBM Recoupments - Average Cost: $127,000
Compound pharmacy claims remained the highest-value target for PBM auditors in 2025. The average recoupment demand for compounding-related audits was more than three times the average for standard retail pharmacy audits.
Auditors focus on ingredient documentation, prescription validity, refill authorization, and pricing accuracy. Compound claims involve more documentation per transaction than standard claims, and the error rate is correspondingly higher. Many pharmacies struggle with the volume of records needed to defend compound claims during an audit.
The appeals process for compound recoupments is particularly challenging because PBMs often apply their own internal compound pricing guidelines retroactively, creating discrepancies that are difficult to contest even when the original claim was processed in good faith.
4. Medicare Part D Documentation Failures - Average Cost: $84,000
CMS and its Plan Sponsor contractors audited more Part D pharmacy claims in 2025 than any prior year. The most common finding was straightforward: the pharmacy could not produce complete documentation to support the claim.
This includes missing prescriptions, missing refill authorizations, absent proof of delivery for mail-order claims, and incomplete signature logs. Part D audits are documentation-centric - if you cannot produce the record, the claim gets recouped regardless of whether the medication was actually dispensed.
The average recoupment demand of $84,000 reflects the extrapolation methodology that auditors use: they audit a sample of claims, calculate an error rate, and apply that rate to the entire claim population for the audit period. A 5% documentation error rate across thousands of claims quickly adds up.
5. State Board License Violations - Average Cost: $52,000
State board penalties are typically lower in dollar terms than federal enforcement, but the operational impact can be severe. License suspensions, mandatory corrective action plans, and increased inspection frequency all carry costs that extend well beyond the fine itself.
The most expensive state board actions in 2025 involved pharmacies operating with expired licenses, operating without a designated pharmacist-in-charge, and repeated deficiencies on follow-up inspections. States are becoming less patient with pharmacies that fail to correct identified deficiencies, and the penalty escalation for repeat violations has steepened across most jurisdictions.
6. OIG Exclusion Screening Failures - Average Cost: $47,000
The penalty for employing an excluded individual who provides services to federal healthcare program beneficiaries is up to $100,000 per item or service, plus treble damages and potential exclusion of the employer. In practice, the settlements we tracked in 2025 averaged $47,000 - reflecting cases where the excluded individual was identified relatively quickly and the claim volume was limited.
The risk here is asymmetric. The screening process itself takes minutes per month when automated. The cost of not screening is potentially catastrophic. Yet many pharmacies still rely on one-time hiring checks and do not re-screen monthly as the OIG recommends.
7. Standard Retail PBM Audit Recoupments - Average Cost: $38,400
Standard (non-compound) PBM audit recoupments round out the list. While the per-audit average is lower than compound claims, the volume of audits is much higher. The three largest PBMs audited over 22,000 pharmacy locations in 2025, making this the most likely compliance cost for any given pharmacy to face.
Common triggers include signature log gaps, dispensing quantity mismatches, DAW code errors, and missing prescriptions. The best defense is prevention - maintaining complete, organized records that can be produced quickly when an audit letter arrives.
The Cost-Benefit Calculation
Adding up the average costs paints a stark picture. A pharmacy that experiences even one of these violations in a year faces financial exposure that dwarfs any investment in compliance infrastructure. The pharmacies that avoid these costs share one characteristic: they have systematic compliance programs that monitor, document, and verify continuously - not just when an inspector calls.
The question for every pharmacy owner is not whether you can afford a compliance program. It is whether you can afford not to have one.
